Literature DB >> 2472033

Coexpression of cytokeratin, neurofilament and vimentin in carcinoid tumors.

N Kimura1, N Sasano, T Namiki, Y Nakazato.   

Abstract

The immunohistochemical expression of intermediate filaments was investigated in 56 carcinoid tumors from 50 cases including 31 rectal and 25 non-rectal sites. Cytokeratin was the most frequently expressed in 55 of the tumours. Only one tumour of the stomach was negative for cytokeratin. Neurofilament (68 kd and 160 kd) was positive in 25 (44.6%) tumours with no preferential pattern of expression in particular tumours. Vimentin was positive in 18 out of the 31 rectal carcinoids (58%), and 3 of the 25 non-rectal carcinoids (12%). There was a significant difference in vimentin immunoreactivity between rectal and non-rectal carcinoids. The coexpression of cytokeratin and neurofilament was 44.6% and that of cytokeratin and vimentin was 37.5%. The coexpression of all three types of intermediate filament was 35.5% in rectal carcinoids, but 8% in non-rectal carcinoids. The present study revealed coexpression of cytokeratin, neurofilament and vimentin in carcinoids and an especially high incidence of vimentin expression in those of rectal origin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472033     DOI: 10.1007/bf00718606

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  38 in total

1.  Expression of neurofilament antigens by normal and neoplastic human adrenal chromaffin cells.

Authors:  J Q Trojanowski; V M Lee
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

2.  Co-expression of vimentin and cytokeratins in parietal endoderm cells of early mouse embryo.

Authors:  E B Lane; B L Hogan; M Kurkinen; J I Garrels
Journal:  Nature       Date:  1983 Jun 23-29       Impact factor: 49.962

3.  Immunoelectronmicroscopical localization of the three neurofilament triplet proteins along neurofilaments of cultured dorsal root ganglion neurones.

Authors:  G A Sharp; G Shaw; K Weber
Journal:  Exp Cell Res       Date:  1982-02       Impact factor: 3.905

4.  Prostate-specific acid phosphatase in carcinoid tumors.

Authors:  N Kimura; N Sasano
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

5.  Bronchial carcinoid cells contain neural-type intermediate filaments.

Authors:  V P Lehto; M Miettinen; D Dahl; I Virtanen
Journal:  Cancer       Date:  1984-08-15       Impact factor: 6.860

6.  An immunohistochemical study of human central and peripheral nervous system tumors, using monoclonal antibodies against neurofilaments and glial filaments.

Authors:  J Q Trojanowski; V M Lee; W W Schlaepfer
Journal:  Hum Pathol       Date:  1984-03       Impact factor: 3.466

7.  Immunohistochemical localization of neurofilaments and neuron-specific enolase in 29 cases of neuroblastoma.

Authors:  M Osborn; T Dirk; H Käser; K Weber; M Altmannsberger
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

8.  Immunochemical identification of intermediate-sized filaments in human neoplastic cells. A diagnostic aid for the surgical pathologist.

Authors:  G Gabbiani; Y Kapanci; P Barazzone; W W Franke
Journal:  Am J Pathol       Date:  1981-09       Impact factor: 4.307

9.  Neurofilaments in adrenal and extra-adrenal pheochromocytoma. Demonstration using immunofluorescence microscopy.

Authors:  V P Lehto; I Virtanen; M Miettinen; D Dahl; A Kahri
Journal:  Arch Pathol Lab Med       Date:  1983-09       Impact factor: 5.534

10.  Redistribution of intermediate filament subunits during skeletal myogenesis and maturation in vitro.

Authors:  G S Bennett; S A Fellini; Y Toyama; H Holtzer
Journal:  J Cell Biol       Date:  1979-08       Impact factor: 10.539

View more
  1 in total

1.  Co-expression of cytokeratin and vimentin filaments in rete testis and epididymis. An immunohistochemical study.

Authors:  H P Dinges; K Zatloukal; C Schmid; S Mair; G Wirnsberger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.